We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

97 hedge funds and large institutions have $127M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 10697 (-9)

11% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 36

32% less capital invested

Capital invested by funds: $185M → $127M (-$58.4M)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
97
Holders Change
-9
Holders Change %
-8.49%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
32
Reduced
36
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$17.2M +$114K +1,067 +0.5%
BlackRock
2
BlackRock
New York
$15.6M +$432K +4,047 +2%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$14.1M +$2.78K +26 +0%
KAM
4
Krensavage Asset Management
New York
$11.1M -$97.6K -914 -0.7%
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.5M +$608K +5,697 +6%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$8.47M +$213K +1,994 +2%
HM
7
HealthCor Management
New York
$6.15M +$7.68M +71,955 New
RSCM
8
Rock Springs Capital Management
Maryland
$5.56M
Renaissance Technologies
9
Renaissance Technologies
New York
$3.32M -$940K -8,806 -19%
State Street
10
State Street
Massachusetts
$3.13M +$77.8K +729 +2%
HC
11
Hillman Company
Pennsylvania
$3.08M
RA
12
Royce & Associates
New York
$3.08M +$981K +9,191 +34%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$2.71M -$341K -3,193 -9%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.24M +$4.48K +42 +0.2%
Northern Trust
15
Northern Trust
Illinois
$2.16M +$135K +1,265 +5%
RCM
16
Rutabaga Capital Management
Massachusetts
$1.66M -$879K -8,229 -30%
Victory Capital Management
17
Victory Capital Management
Texas
$1.4M +$69.3K +649 +4%
FP
18
Foundry Partners
Minnesota
$1.24M -$87.1K -816 -5%
KIA
19
Kopp Investment Advisors
Minnesota
$1.18M -$1.09M -10,227 -42%
CLG
20
Cooperman Leon G
$1.06M +$454K +4,249 +52%
N
21
Nuveen
North Carolina
$780K -$45.6K -427 -4%
SBH
22
Segall Bryant & Hamill
Illinois
$764K +$164K +1,534 +21%
BCM
23
Bridgeway Capital Management
Texas
$689K -$225K -2,104 -21%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$640K +$43.5K +407 +6%
Grantham, Mayo, Van Otterloo & Co (GMO)
25
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$599K +$283K +2,650 +61%

SRGA Hedge Fund Activity: Q3 2019 in Review

97 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2019, worth a combined $127M — down 32% from $185M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SRGA and 6 opened new positions — a net loss of 9 holders — while 36 trimmed existing stakes and 32 added.

The largest buyer was HealthCor Management, opening a new position worth an estimated $7.68M. The largest seller was Wedge Capital Management, exiting entirely with an estimated $1.36M sold.

  • 97 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2019, down from 106 in Q2 2019.
  • Funds reported $127M of Surgalign Holdings, Inc. Common Stock stock for Q3 2019, down 32% quarter-over-quarter.
  • 6 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2019 and 15 closed out, a net change of -9 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2019 was HealthCor Management, an estimated $7.68M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2019 was Wedge Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q3 2019.